267 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
RSS Create an RSS feed from your search for:
"Expanded Access" [STUDY-TYPES]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Approved for marketing VX-770 Expanded Access Program
Condition: Cystic Fibrosis
Intervention: Drug: VX-770
2 Approved for marketing The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol
Condition: Hemoglobinuria, Paroxysmal
Intervention: Drug: eculizumab
3 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
4 Available An Extended Access Program for Perampanel
Condition: Partial Onset Seizures
Intervention: Drug: Perampanel
5 Available 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS);   Congenital Myasthenia (CM)
Intervention: Drug: 3,4-diaminopyridine
6 Available Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 DAP
7 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven
8 Available Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Condition: Chronic Myeloid Leukemia
Intervention: Drug: bosutinib
9 Available Treatment of Lambert-Eaton Syndrome With 3,4 DAP
Condition: Lambert Eaton Myasthenic Syndrome
Intervention: Drug: 3, 4 DAP
10 Approved for marketing Post Approval Continued Access Study of the MENTOR® Contour Profile Gel Breast Implant
Conditions: Breast Augmentation;   Breast Reconstruction;   Breast Revision
Intervention: Device: Mentor Siltex® Contour Profile Gel Mammary Prosthesis
11 Approved for marketing ALIMTA (Pemetrexed) Alone or in Combination With Cisplatin for Patients With Malignant Mesothelioma.
Condition: Mesothelioma
Interventions: Drug: Pemetrexed;   Drug: Cisplatin
12 Approved for marketing A Belatacept Compassionate Use Study for Patients With a Kidney Transplant
Condition: Renal Transplantation
Intervention: Drug: Belatacept
13 Approved for marketing Provide Expanded Access to MDV3100 and Monitor Its Safety in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
Condition: Metastatic Castration-Resistant Prostate Cancer
Intervention: Drug: MDV3100
14 No longer available Post Marketing Surveillance Study of Cuprimine
Condition: Scleroderma
Intervention: Drug: Cuprimine (penicillamine)
15 No longer available Use of the Pressure Right Device After Laparoscopic Surgery
Conditions: Nausea;   Vomiting
Intervention: Device: Acupressure
16 No longer available YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access
Condition: Soft Tissue Sarcoma
Intervention: Drug: Trabectedin
17 Available Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: nintedanib
18 Approved for marketing Emergency/Compassionate Use - Muscular VSD Occluder
Conditions: Muscular;   Ventricular;   Septal;   Defects;   VSD
Intervention: Device: AMPLATZER Muscular VSD Occluder
19 Approved for marketing A Treatment Protocol for Patients With Gastrointestinal Stromal Tumor (GIST) Who May Derive Benefit From Treatment With SU011248
Condition: Gastrointestinal Neoplasm
Intervention: Drug: Sutent
20 Unknown  Clinical Research on the Efficacy of Acupuncture Treatment in Chronic Low Back Pain
Conditions: Chronic Low Back Pain;   Acupuncture
Intervention: Device: Acupuncture, Pak-sham needle

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years